9061 related articles for article (PubMed ID: 15055260)
1. High levels of sFas and PBMC apoptosis before and after excision of malignant melanoma--case report.
Alecu M; Coman G; Dănăilă L
Roum Arch Microbiol Immunol; 2002; 61(4):267-73. PubMed ID: 15055260
[TBL] [Abstract][Full Text] [Related]
2. Serological levels of apoptotic bodies, sFAS and TNF in lupus erythematosus.
Alecu M; Coman G; Alecu S
Rom J Intern Med; 2000-2001; 38-39():83-8. PubMed ID: 15529575
[TBL] [Abstract][Full Text] [Related]
3. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.
Grzegorczyk J; Kowalski ML; Pilat A; Iwaszkiewicz J
Mediators Inflamm; 2002 Aug; 11(4):225-33. PubMed ID: 12396474
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of blood mononuclear cells in alcoholic liver cirrhosis. The influence of in vitro ethanol treatment and zinc supplementation.
Szuster-Ciesielska A; Daniluk J; Bojarska-Junak A
Toxicology; 2005 Sep; 212(2-3):124-34. PubMed ID: 15964121
[TBL] [Abstract][Full Text] [Related]
5. Modulation of sFas indicates apoptosis in human herpes simplex encephalitis.
Sabri F; Granath F; Hjalmarsson A; Aurelius E; Sköldenberg B
J Neuroimmunol; 2006 Feb; 171(1-2):171-6. PubMed ID: 16325272
[TBL] [Abstract][Full Text] [Related]
6. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
7. Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings.
Baba K; Minatoguchi S; Sano H; Kagawa T; Murata I; Takemura G; Hirano T; Ohashi H; Takemura M; Fujiwara T; Fujiwara H
Nephrology (Carlton); 2004 Apr; 9(2):94-9. PubMed ID: 15056269
[TBL] [Abstract][Full Text] [Related]
8. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
[TBL] [Abstract][Full Text] [Related]
9. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of apoptosis markers in advanced heart failure patients.
Niessner A; Hohensinner PJ; Rychli K; Neuhold S; Zorn G; Richter B; Hülsmann M; Berger R; Mörtl D; Huber K; Wojta J; Pacher R
Eur Heart J; 2009 Apr; 30(7):789-96. PubMed ID: 19196721
[TBL] [Abstract][Full Text] [Related]
11. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
[TBL] [Abstract][Full Text] [Related]
12. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
13. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
16. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M
Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967
[TBL] [Abstract][Full Text] [Related]
17. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
19. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma.
Mezei G; Lévay M; Sepler Z; Héninger E; Kozma GT; Cserháti E
Pediatr Allergy Immunol; 2006 Sep; 17(6):444-9. PubMed ID: 16925690
[TBL] [Abstract][Full Text] [Related]
20. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
